Vernalis Group, Eli Lilly, Roche deal

LLY obtained an option to develop VER’s VML 670 to treat sexual dysfunction in patients taking selective

Read the full 179 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE